PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway

No abstract is available for this paper.

• Publication year

  2015

• Venue

  In Vitro Cellular & Developmental Biology - Animal

• Publication date

  2015-07-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11626-015-9931-xPMID 26170223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Curcumin induces glioma stem-like cell formation

  2015cited by this paper
• Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways.

  2015cited by this paper
• miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.

  2015cited by this paper
• ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity.

  2015cited by this paper
• EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXM1-Dependent Manner

  2015cited by this paper
• Efficacy of rapamycin against glioblastoma cancer stem cells

  2014cited by this paper
• miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1

  2014cited by this paper
• Anti-neoplastic activity of low-dose endothelial-monocyte activating polypeptide-II results from defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis in human glioblastoma stem cells.

  2014cited by this paper
• RETRACTED ARTICLE: MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma

  2014cited by this paper
• miR-125b Inhibitor May Enhance the Invasion-Prevention Activity of Temozolomide in Glioblastoma Stem Cells by Targeting PIAS3

  2014cited by this paper
• Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting known targets but by down-regulating a novel set of core genes

  2014cited by this paper
• Primary malignant brain tumours, psychosocial distress and the intimate partner experience: what do we know?

  2014cited by this paper
• Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.

  2014cited by this paper
• Downregulation of SCAI enhances glioma cell invasion and stem cell like phenotype by activating Wnt/β-catenin signaling.

  2014cited by this paper
• MicroRNA-125b inhibitor sensitizes human primary glioblastoma cells to chemotherapeutic drug temozolomide on invasion

  2013cited by this paper
• Suppression of Cholangiocarcinoma Cell Growth by Human Umbilical Cord Mesenchymal Stem Cells: A Possible Role of Wnt and Akt Signaling

  2013cited by this paper
• Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.

  2013cited by this paper
• 14-3-3β regulates the proliferation of glioma cells through the GSK3β/β-catenin signaling pathway.

  2013cited by this paper
• FoxM1 and Wnt/β-catenin signaling in glioma stem cells.

  2012cited by this paper
• Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.

  2012cited by this paper
• LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway.

  2011cited by this paper
• Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling

  2010cited by this paper
• BMP-4 induction of arrest and differentiation of osteoblast-like cells via p21 CIP1 and p27 KIP1 regulation.

  2009cited by this paper

• Exosomal circular RNAs as drivers of temozolomide resistance in glioblastoma: Mechanisms and implications.

  2025cites this paper
• Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances

  2025cites this paper
• Cancer Stem Cell Regulation as a Target of Therapeutic Intervention: Insights into Breast, Cervical and Lung Cancer

  2025cites this paper
• Hunting glioblastoma recurrence: glioma stem cells as retrospective targets.

  2025cites this paper
• The immunomodulatory role of tumor-initiating cells in digestive system tumors: from mechanisms to therapy

  2025cites this paper
• MicroRNAs in adult high-grade gliomas: Mechanisms of chemotherapeutic resistance and their clinical relevance.

  2024cites this paper
• Non-Coding RNA as a Biomarker in Lung Cancer

  2024cites this paper
• Role of Non-coding RNAs in the Response of Glioblastoma to Temozolomide

  2024cites this paper
• MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma

  2024cites this paper
• Emerging Insights into the PI3K/AKT/mTOR Signaling Pathway and Non-Coding RNA-mediated Drug Resistance in Glioblastoma.

  2024cites this paper
• Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma

  2024cites this paper
• Tumor microenvironment-induced tumor cell plasticity: relationship with hypoxic stress and impact on tumor resistance

  2023cites this paper
• Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia

  2023cites this paper
• Zebrafish Drug Screening Identifies Erlotinib as an Inhibitor of Wnt/β-Catenin Signaling and Self-Renewal in T-cell Acute Lymphoblastic Leukemia

  2023cites this paper
• DNA methylation-induced ablation of miR-133a accelerates cancer aggressiveness in glioma through upregulating peroxisome proliferator-activated receptor γ.

  2022cites this paper
• Up-regulation of miR-30b suppresses glioblastoma by negatively regulating MEF2D through Wnt/β-catenin signaling pathway

  2022cites this paper
• Non-coding RNAs and glioma: Focus on cancer stem cells

  2022cites this paper
• A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1

  2021cites this paper
• Targeting the molecular mechanisms of glioma stem cell resistance to chemotherapy

  2021cites this paper
• Regulatory interplay between microRNAs and WNT pathway in glioma.

  2021cites this paper
• Circular RNAs in stem cells: from basic research to clinical implications

  2021cites this paper
• RUNX1 (RUNX family transcription factor 1), a target of microRNA miR-128-3p, promotes temozolomide resistance in glioblastoma multiform by upregulating multidrug resistance-associated protein 1 (MRP1)

  2021cites this paper
• Essential functions of miR‐125b in cancer

  2020cites this paper
• Targeting cancer stem cell pathways for cancer therapy

  2020cites this paper
• MiRNA-27a-3p induces temozolomide resistance in glioma by inhibiting NF1 level.

  2020cites this paper
• Therapeutically Significant MicroRNAs in Primary and Metastatic Brain Malignancies

  2020cites this paper
• miRNA signature in glioblastoma: Potential biomarkers and therapeutic targets.

  2020cites this paper
• Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis

  2020cites this paper
• MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies

  2020cites this paper
• DNA methylation regulates glioma cell cycle through down-regulating MiR-133a-5p expression

  2020influential citation
• DNA methylation regulates glioma cell cycle through down-regulating MiR-133a expression

  2019influential citation
• Methylation-induced downregulation and tumor-suppressive role of microRNA-98 in glioma through targeting Sal-like protein 4

  2018cites this paper
• WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma

  2018cites this paper
• Wnt/β‐catenin signaling cascade: A promising target for glioma therapy

  2018cites this paper
• MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma

  2018cites this paper
• [Erythropoietin accelerates the proliferation of glioma cells via activating Akt pathway].

  2018cites this paper
• miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.

  2017cites this paper
• Tetrandrine inhibits glioma stem-like cells by repressing β-catenin expression.

  2017cites this paper
• Up‐regulation of miR‐497 confers resistance to temozolomide in human glioma cells by targeting mTOR/Bcl‐2

  2017cites this paper
• BMI-1 Promotes Self-Renewal of Radio- and Temozolomide (TMZ)-Resistant Breast Cancer Cells

  2017cites this paper
• Glioma Stem-Like Cells in Tumor Growth and Therapy Resistance of Glioblastoma

  2017cites this paper
• miRNA-125 b regulates apoptosis of human non-small cell lung cancer via the PI 3 K / Akt / GSK 3 β signaling pathway

  2017cites this paper
• Advances in Biology and Treatment of Glioblastoma

  2017cites this paper
• miR‑146b‑5p suppresses glioblastoma cell resistance to temozolomide through targeting TRAF6.

  2017cites this paper
• SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways.

  2016cites this paper
• MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.

  2016cites this paper
• MiR‐125b regulates SFRP5 expression to promote growth and activation of cardiac fibroblasts

  2016cites this paper
• WNT/β-catenin Signaling Pathway and Downstream Modulators in Low- and High-grade Glioma.

  2016cites this paper
• MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-β1.

  2016cites this paper
• MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics

  2016cites this paper
• Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo

  2016cites this paper
• KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation

  2016cites this paper